Your browser doesn't support javascript.
loading
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Dearnaley, David; Syndikus, Isabel; Mossop, Helen; Khoo, Vincent; Birtle, Alison; Bloomfield, David; Graham, John; Kirkbride, Peter; Logue, John; Malik, Zafar; Money-Kyrle, Julian; O'Sullivan, Joe M; Panades, Miguel; Parker, Chris; Patterson, Helen; Scrase, Christopher; Staffurth, John; Stockdale, Andrew; Tremlett, Jean; Bidmead, Margaret; Mayles, Helen; Naismith, Olivia; South, Chris; Gao, Annie; Cruickshank, Clare; Hassan, Shama; Pugh, Julia; Griffin, Clare; Hall, Emma.
Afiliação
  • Dearnaley D; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: David.Dearnaley@icr.ac.uk.
  • Syndikus I; Clatterbridge Cancer Centre, Wirral, UK.
  • Mossop H; The Institute of Cancer Research, London, UK.
  • Khoo V; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
  • Birtle A; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK.
  • Bloomfield D; Brighton and Sussex University Hospitals, Brighton, UK.
  • Graham J; Beacon Centre, Musgrove Park Hospital, Taunton, UK.
  • Kirkbride P; Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK.
  • Logue J; Christie Hospital, Manchester, UK.
  • Malik Z; Clatterbridge Cancer Centre, Wirral, UK.
  • Money-Kyrle J; Royal Surrey County Hospital, Guildford, UK.
  • O'Sullivan JM; Queen's University Belfast, Belfast, UK.
  • Panades M; Lincoln County Hospital, Lincoln, UK.
  • Parker C; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
  • Patterson H; Addenbrooke's Hospital, Cambridge, UK.
  • Scrase C; Ipswich Hospital, Ipswich, UK.
  • Staffurth J; Cardiff University/Velindre Cancer Centre, Cardiff, UK.
  • Stockdale A; University Hospital Coventry, Coventry, UK.
  • Tremlett J; Brighton and Sussex University Hospitals, Brighton, UK.
  • Bidmead M; Royal Marsden NHS Foundation Trust, London, UK.
  • Mayles H; Clatterbridge Cancer Centre, Wirral, UK.
  • Naismith O; Royal Marsden NHS Foundation Trust, London, UK.
  • South C; Royal Surrey County Hospital, Guildford, UK.
  • Gao A; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
  • Cruickshank C; The Institute of Cancer Research, London, UK.
  • Hassan S; The Institute of Cancer Research, London, UK.
  • Pugh J; The Institute of Cancer Research, London, UK.
  • Griffin C; The Institute of Cancer Research, London, UK.
  • Hall E; The Institute of Cancer Research, London, UK.
Lancet Oncol ; 17(8): 1047-1060, 2016 Aug.
Article em En | MEDLINE | ID: mdl-27339115
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radioterapia de Intensidade Modulada / Hipofracionamento da Dose de Radiação Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radioterapia de Intensidade Modulada / Hipofracionamento da Dose de Radiação Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article